11/06/2021
https://maonline.jp/articles/shionogi_marianna20210611
新型コロナウイルス感染者の重症化リスクの判定や、後遺症の見守りが行えるようになった。塩野義製薬や聖マリアンナ医科大学病院などの成果で、ワクチン普及後も重症化や後遺症などに対するニーズは少なくなさそうだ...
Improve the health of Companion Animals (CA) such dogs and cats with introduction of Evidence Based Medicine (EBM) into veterinary fields.
BLDG5, NO. 6 WEST AV. , HKSP
Hong Kong
Be the first to know and let us send you an email when Amgin Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.